查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1267715

靶向测序和重测序全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Targeted Sequencing And Resequencing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2个工作天内

价格

靶向测序和重测序是两种用于研究基因组特定区域的 DNA 测序技术。 靶向测序有选择地对基因组内感兴趣的特定区域进行测序。 这是通过使用设计用于仅结合和扩增所需 DNA 区域的探针或引物来实现的。 靶向测序可用于研究特定基因或感兴趣区域，例如与特定疾病相关的基因或区域。 另一方面，重测序是对整个基因组或基因组特定区域进行测序，以识别遗传变异和突变。 该技术可用于比较不同个体或人群的 DNA 序列，以确定可能与疾病或其他特征相关的差异。

市场动态

精准医学是利用遗传信息制定个性化治疗计划。 靶向测序和重测序技术对于识别导致或促成疾病的基因突变以及製定个体化治疗计划是必不可少的。 癌症、罕见遗传病和心血管疾病等遗传性疾病的患病率在世界范围内呈上升趋势。 靶向测序和重测序技术是识别可能导致这些疾病的基因突变和开发靶向疗法的重要工具。 测序技术的进步使靶向测序和重测序更快、更准确且成本更低。 这导致这些技术在研究和临床环境中得到广泛采用。 为了了解疾病的遗传基础并开发新的治疗方法，各国政府对基因组研究进行了大量投资。 这推动了对靶向测序和重测序技术的需求。 人们越来越意识到基因检测对疾病风险评估、家谱分析和个性化医疗的好处。 这推动了消费者基因组学市场对靶向测序和重测序服务的需求。

这份研究报告解释了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外，这些工具还能够全面评估全球靶向测序和重测序市场的每个细分市场。 靶向测序和重测序行业的发展和趋势为这项研究提供了一种整体方法。

市场细分

本节提供有关靶向测序和再测序市场报告的国家和区域级部分的详细数据，从而帮助战略制定者确定目标受众和他们各自产品或服务的即将到来的机会。它旨在支持

技术

  • 测序
  • 重测序（电泳重测序、Ngs、阵列重测序）

按申请

  • 临床应用
  • 植物和动物科学
  • 药物开发
  • 其他

按类型

  • 基于 DNA 的目标测序
  • 基于 RNA 的目标测序

按最终用途

  • 医院和诊所
  • 学术研究
  • 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲、中东和非洲的靶向测序和重测序市场当前和未来的需求。 此外，该报告重点关注所有主要地区每个单独应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 靶向测序和重测序市场的主要参与者是安捷伦科技、Illumina Inc.、F. Hoffmann-La Roche Ltd、GATC Biotech Ag、DNASTAR Inc.、QIAGEN、BGI、Oxford Nanopore Technology、Thermo Fisher Scientific, Inc. PerkinElmer、PacBio , RainDance Technologies Inc, Bio-Rad Laboratories, Integrated DNA Technologies, Pyriandex, Genomics, Macrogen Inc. 本节涵盖主要併购、未来能力、合作伙伴关係、财务概览、合作，它包括对竞争格局的概述，包括各种战略开发，例如新产品开发和新产品发布。

如果您有任何定制要求，请写信给我们。 我们的研究团队可以根据您的需要提供定制报告。

内容

第一章前言

  • 报告内容
    • 目的
    • 目标受众
    • USP（独特的销售建议）及其提供的内容
  • 调查范围
  • 调查方法
    • 市场调研流程
    • 市场研究方法

第 2 章执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章靶向测序和重测序 - 行业分析

  • 简介 - 市场动态
  • 市场驱动力
  • 市场製约因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按技术进行市场吸引力分析
    • 市场吸引力分析：按应用
    • 按类型进行市场吸引力分析
    • 按最终用途进行的市场吸引力分析
    • 市场吸引力分析：按地区

第四章价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料製造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 市场发展趋势

第 5 章靶向测序和重测序全球市场分析：按技术分类

  • 技术概述
  • 过去和未来的数据
  • 技术分析
  • 测序
  • 重测序（电泳重测序、Ngs、阵列重测序）

第 6 章靶向测序和重测序的全球市场分析：按应用

  • 总结：按应用
  • 过去和未来的数据
  • 分析：按应用
  • 临床应用
  • 植物和动物科学
  • 药物开发
  • 其他

第 7 章靶向测序和重测序的全球市场分析：按类型

  • 按类型概述
  • 过去和未来的数据
  • 按类型分析
  • 基于 DNA 的目标测序
  • 基于 RNA 的目标测序

第 8 章靶向测序和重测序的全球市场分析：按最终用途分类

  • 按最终用途汇总
  • 过去和未来的数据
  • 最终用途分析
  • 医院和诊所
  • 学术研究
  • 其他

第 9 章靶向测序和重测序全球市场分析：按地区

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、销售业绩和预测分析
    • 北美各部门的销售分析
    • 北美销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、销售业绩和预测分析
    • 按细分市场进行的欧洲销售分析
    • 按国家/地区划分的欧洲销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 其他欧洲销售分析
  • 亚太地区销售分析
    • 概览、销售业绩和预测分析
    • 亚太地区各部门的销售分析
    • 亚太国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本的销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 其他亚太地区销售分析
  • 拉丁美洲销售分析
    • 概览、销售业绩和预测分析
    • 拉丁美洲各部门的销售分析
    • 拉丁美洲国家/地区的销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利的销售分析
    • 其他拉丁美洲销售分析
  • 中东和非洲销售分析
    • 概览、销售业绩和预测分析
    • 中东和非洲各细分市场的销售额分析
    • 中东和非洲国家/地区的销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 其他中东和非洲销售分析

第10章：靶向测序和重测序公司的竞争格局

  • 靶向测序和重测序市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他扩展

第11章公司简介

  • 公司股票分析
  • 市场集中度
  • 安捷伦科技
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 因美纳公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • F. Hoffmann-La Roche Ltd.
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • GATC 生物科技公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • DNASTAR 公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 凯杰
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 华大基因
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 牛津纳米孔技术公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 珀金埃尔默公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • PacBio
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • Rain Dance Technologies Inc.
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • Bio-Rad 实验室公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • Integrated DNA Technologies Inc.
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • PierianDx
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • Genomatix 有限公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 宏基因公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势

注意：公司简介中的财务细节和近期发展基于可用信息，私营公司可能不包括在内。

Product Code: VMR112110809

The global demand for Targeted Sequencing And Resequencing Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.

Targeted sequencing and resequencing are two types of DNA sequencing techniques used to study specific regions of the genome. Targeted sequencing involves selectively sequencing specific regions of interest within the genome. This is achieved by using probes or primers that are designed to bind to and amplify only the desired regions of DNA. Targeted sequencing is useful for studying specific genes or regions of interest, such as those associated with a particular disease. Resequencing, on the other hand, involves sequencing an entire genome or a specific region of the genome to identify genetic variations or mutations. This technique is useful for comparing the DNA sequences of different individuals or populations to identify differences that may be associated with disease or other traits.

Market Dynamics

Precision medicine involves using genetic information to develop personalized treatment plans for patients. Targeted sequencing and resequencing technologies are critical for identifying genetic mutations that can cause or contribute to disease and for developing personalized treatment plans. The prevalence of genetic diseases such as cancer, rare genetic disorders, and cardiovascular diseases is increasing globally. Targeted sequencing and resequencing technologies are important tools for identifying genetic mutations that may cause these diseases, as well as for developing targeted therapies. Advances in sequencing technologies have made targeted sequencing and resequencing faster, more accurate, and more affordable. This has led to wider adoption of these technologies in research and clinical settings. Heavy investment in genomics research by various governments and to understand the genetic basis of diseases and develop new treatments. This is driving the demand for targeted sequencing and resequencing technologies. There is a growing awareness among individuals about the benefits of genetic testing for disease risk assessment, ancestry analysis, and personalized medicine. This is driving the demand for targeted sequencing and resequencing services in the consumer genomics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of targeted sequencing and resequencing. The growth and trends of targeted sequencing and resequencing industry provide a holistic approach to this study.

Market Segmentation

This section of the targeted sequencing and resequencing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • Sequencing
  • Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing)

By Application

  • Clinical Application
  • Plant And Animal Sciences
  • Drug Development
  • Others

By Type

  • DNA-Based Targeted Sequencing
  • RNA-Based Targeted Sequencing

By End-Use

  • Hospitals & Clinics
  • Academic Research
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Targeted Sequencing And Resequencing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the targeted sequencing and resequencing market include Agilent Technologies, Illumina Inc., F. Hoffmann-La Roche Ltd, GATC Biotech Ag, DNASTAR Inc., QIAGEN, BGI, Oxford Nanopore Technologies, Thermo Fisher Scientific Inc., Perkin Elmer Inc., PacBio, RainDance Technologies Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., PierianDx, Genomatix GmbH, Macrogen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . TARGETED SEQUENCING AND RESEQUENCING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Type
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY TECHNOLOGY

  • 5.1 Overview by Technology
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Technology
  • 5.4 Sequencing Historic and Forecast Sales by Regions
  • 5.5 Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing) Historic and Forecast Sales by Regions

6 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Clinical Application Historic and Forecast Sales by Regions
  • 6.5 Plant And Animal Sciences Historic and Forecast Sales by Regions
  • 6.6 Drug Development Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 DNA-Based Targeted Sequencing Historic and Forecast Sales by Regions
  • 7.5 RNA-Based Targeted Sequencing Historic and Forecast Sales by Regions

8 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY END-USE

  • 8.1 Overview by End-Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-Use
  • 8.4 Hospitals & Clinics Historic and Forecast Sales by Regions
  • 8.5 Academic Research Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE TARGETED SEQUENCING AND RESEQUENCING COMPANIES

  • 10.1. Targeted Sequencing And Resequencing Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF TARGETED SEQUENCING AND RESEQUENCING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Agilent Technologies
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Illumina Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. F. Hoffmann-La Roche Ltd
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. GATC Biotech Ag
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. DNASTAR Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. QIAGEN
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. BGI
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Oxford Nanopore Technologies
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Perkin Elmer Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. PacBio
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. RainDance Technologies Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Bio-Rad Laboratories Inc.
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Integrated DNA Technologies Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. PierianDx
    • 11.17.1. Company Overview
    • 11.17.2. Company Revenue
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. Genomatix GmbH
    • 11.18.1. Company Overview
    • 11.18.2. Company Revenue
    • 11.18.3. Products
    • 11.18.4. Recent Developments
  • 11.19. Macrogen Inc.
    • 11.19.1. Company Overview
    • 11.19.2. Company Revenue
    • 11.19.3. Products
    • 11.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Technology (USD MN)
  • Sequencing Market Sales by Geography (USD MN)
  • Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing) Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Clinical Application Market Sales by Geography (USD MN)
  • Plant And Animal Sciences Market Sales by Geography (USD MN)
  • Drug Development Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Type (USD MN)
  • DNA-Based Targeted Sequencing Market Sales by Geography (USD MN)
  • RNA-Based Targeted Sequencing Market Sales by Geography (USD MN)
  • Analysis by End-Use (USD MN)
  • Hospitals & Clinics Market Sales by Geography (USD MN)
  • Academic Research Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Targeted Sequencing And Resequencing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Targeted Sequencing And Resequencing Report
  • Market Research Process
  • Market Research Methodology
  • Global Targeted Sequencing And Resequencing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Technology (USD MN)
  • Sequencing Market Sales by Geography (USD MN)
  • Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing) Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Clinical Application Market Sales by Geography (USD MN)
  • Plant And Animal Sciences Market Sales by Geography (USD MN)
  • Drug Development Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • DNA-Based Targeted Sequencing Market Sales by Geography (USD MN)
  • RNA-Based Targeted Sequencing Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Hospitals & Clinics Market Sales by Geography (USD MN)
  • Academic Research Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.